NCT03146949

Brief Summary

This study compares two oxygenators commonly in use to establish whether they effect the amount of isoflurane in the patient's blood. Half of the patients will be placed in a group using the Sorin Inspire oxygenator and half into the group using the Medtronic Affinity Fusion oxygenator.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
25

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2017

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 5, 2017

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

April 6, 2017

Completed
20 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 26, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 26, 2017

Completed
14 days until next milestone

First Posted

Study publicly available on registry

May 10, 2017

Completed
Last Updated

May 23, 2024

Status Verified

May 1, 2024

Enrollment Period

4 months

First QC Date

April 6, 2017

Last Update Submit

May 22, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Arterial blood concentration of isoflurane

    6ml sample of blood will be taken at three time points during an operation requiring cardiopulmonary bypass. This blood will be analysed using gas chromatography and mass spectrometry in order to quantify isoflurane concentrations. Mean values will be calculated for each participant, and then an overall mean will be produced for each oxygenator. This will then be compared using independent-samples t-test.

    Application of aortic cross clamp, 20 minutes after application, removal of aortic cross clamp.

Secondary Outcomes (3)

  • Change in Bispectral Index Score (BIS)

    Application of aortic cross clamp, 20 minutes after application, removal of aortic cross clamp.

  • Change in arterial temperature

    Application of aortic cross clamp, 20 minutes after application, removal of aortic cross clamp.

  • Change in exhaust isoflurane concentration

    Application of aortic cross clamp, 20 minutes after application, removal of aortic cross clamp.

Study Arms (2)

Sorin Inspire Oxygenator

ACTIVE COMPARATOR

Sorin Inspire Oxygenator is used on the cardiopulmonary bypass machine

Device: Sorin Inspire Oxygenator

Medtronic Affinity Fusion Oxygenator

ACTIVE COMPARATOR

Medtronic Affinity Fusion Oxygenator is used on the cardiopulmonary bypass machine

Device: Medtronic Affinity Fusion

Interventions

This is an oxygenator manufactured by the Sorin group. It is a hollow fibre polypropylene oxygenator.

Sorin Inspire Oxygenator

This is an oxygenator manufactured by the Medtronic group. It is a hollow fibre polypropylene oxygenator.

Medtronic Affinity Fusion Oxygenator

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • aged 18 years or older
  • who have given their consent to participate
  • scheduled for elective cardiac surgery requiring CPB

You may not qualify if:

  • unwilling or unable to provide informed consent
  • presenting for emergency surgery
  • undergoing cardiac surgery without CPB
  • in whom total intravenous anaesthesia (TIVA) is being used

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Royal Infirmary Edinburgh

Edinburgh, EH16 4SA, United Kingdom

Location

Study Officials

  • Peter Alston

    Honorary Clinical Senior Lecturer and Consultant Anaesthetist

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Primary outcome assessor is masked. The primary outcome involves the analysis of blood concentrations of isoflurane, and the laboratory will not be given information on allocation.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 6, 2017

First Posted

May 10, 2017

Study Start

January 5, 2017

Primary Completion

April 26, 2017

Study Completion

April 26, 2017

Last Updated

May 23, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will not share

Locations